Business · 09/06/20201 min read

FDA Releases Guidance for Institutional Review Boards Reviewing Individual Patient Expanded Access Requests for COVID-19 Treatments

The FDA has issued a final guidance to help Institutional Review Boards (IRBs) review individual patient expanded access requests for investigational COVID-19 treatments, allowing patients to access these treatments during the public health emergency.